Search results
Americans Are Spending the Most Money on These 25 Prescription Drugs
Healthline· 6 days agoThe diabetes and weight loss medication semaglutide (Ozempic, Wegovy, and Rybelsus) topped the list....
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 6 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Perioperative Nivolumab Boosts EFS in Resectable Lung Cancer
MedPage Today· 7 days agoCheckMate 77T trial shows 42% reduction in risk of tumor recurrence, progression, or death
Cramer says these 10 stocks helped the Dow briefly crack 40,000
CNBC· 5 days agoCNBC's Jim Cramer listed ten stocks that helped the Dow Jones Industrial Average briefly top 40,000 on Thursday, a new high for the index. "To me, this list is emblematic of the fact that we ...
Atezolizumab Plus Chemo Falters in Rapidly Relapsing TNBC
MedPage Today· 6 days agoCombining atezolizumab (Tecentriq) with chemotherapy for patients with rapidly relapsing,...
Top Stock Reports for Broadcom, Merck & Airbnb
Zacks· 7 days agoThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Merck ...
Here's the moment Nvidia became the AI king and what it must do this week to keep the throne
CNBC· 2 days agoEvery time he does, he knows he gets a laugh from me, although my wife was a little baffled about how it could be a "miss" when Jensen told the same joke to her. No one is laughing about Jayshree's ...
MRK- A Big Pharma Name Growing Via Acquisitions, Product Launches
MoneyShow via Yahoo Finance· 7 days agoMerck & Co. (MRK) is a leading global drugmaker, producing a wide range of prescription drugs and vaccines in many therapeutic areas in the US and abroad. The US is MRK’s largest market, accounting ...
Q1 2024 AIM ImmunoTech Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoWe also announced the topline interim data indicating that the combination of Ampligen with Keytruda, also known as pembrolizumab, in the treatment of recurrent ovarian cancer ...
